These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 24905320

  • 1. The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits.
    Bienert A, Płotek W, Wiczling P, Kostrzewski B, Kamińska A, Billert H, Szczesny D, Zaba C, Teżyk A, Buda K, Bednarek E, Kaliszan R, Grześkowiak E.
    Pharmacol Rep; 2014 Feb; 66(1):143-52. PubMed ID: 24905320
    [Abstract] [Full Text] [Related]

  • 2. Influence of time of day on propofol pharmacokinetics and pharmacodynamics in rabbits.
    Bienert A, Płotek W, Zawidzka I, Ratajczak N, Szczesny D, Wiczling P, Kokot ZJ, Matysiak J, Grześkowiak E.
    Chronobiol Int; 2011 May; 28(4):318-29. PubMed ID: 21539423
    [Abstract] [Full Text] [Related]

  • 3. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
    Bienert A, Bartkowska-Sniatkowska A, Wiczling P, Rosada-Kurasińska J, Grześkowiak M, Zaba C, Teżyk A, Sokołowska A, Kaliszan R, Grześkowiak E.
    Pharmacol Rep; 2013 May; 65(1):107-21. PubMed ID: 23563029
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolam.
    Tomalik-Scharte D, Suleiman AA, Frechen S, Kraus D, Kerkweg U, Rokitta D, Di Gion P, Queckenberg C, Fuhr U.
    J Clin Pharmacol; 2014 Oct; 54(10):1162-9. PubMed ID: 24782075
    [Abstract] [Full Text] [Related]

  • 5. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A, Karim A, Feldman J, Kharasch E.
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [Abstract] [Full Text] [Related]

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM.
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [Abstract] [Full Text] [Related]

  • 7. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J, Lichtenbelt BJ, Olofsen E, van Kleef JW, Dahan A.
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [Abstract] [Full Text] [Related]

  • 8. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, Schüttler J.
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN.
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effects on respiratory carbon dioxide response, arterial blood pressure, and heart rate of dexmedetomidine, propofol, and midazolam in sevoflurane-anesthetized rabbits.
    Chang C, Uchiyama A, Ma L, Mashimo T, Fujino Y.
    Anesth Analg; 2009 Jul; 109(1):84-9. PubMed ID: 19535698
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
    Peeters MY, Prins SA, Knibbe CA, Dejongh J, Mathôt RA, Warris C, van Schaik RH, Tibboel D, Danhof M.
    Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
    Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U.
    Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E.
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [Abstract] [Full Text] [Related]

  • 14. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM.
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [Abstract] [Full Text] [Related]

  • 15. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Hering W, Ihmsen H, Albrecht S, Schwilden H, Schüttler J.
    Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
    Simon BT, Scallan EM, O O, Ebner LS, Cerullo MN, Follette C, Cox SK, Doherty TJ, Lizarraga I.
    Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
    Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM.
    Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
    [Abstract] [Full Text] [Related]

  • 18. Exercise alters the pharmacokinetics of midazolam.
    Strömberg C, Vanakoski J, Olkkola KT, Lindqvist A, Seppälä T, Laitinen LA.
    Clin Pharmacol Ther; 1992 May; 51(5):527-32. PubMed ID: 1587067
    [Abstract] [Full Text] [Related]

  • 19. Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential.
    Fukuta O, Braham RL, Yanase H, Kurosu K.
    ASDC J Dent Child; 1997 May; 64(2):89-98. PubMed ID: 9188997
    [Abstract] [Full Text] [Related]

  • 20. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J, van Gerven JM, Schoemaker RC, Roncari G, Oberyé JJ, van Oostenbruggen MF, Massarella J, Segala P, Zell M, Cohen AF.
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.